Orange Book product · Generic (ANDA)
SILODOSIN
SILODOSIN
At a glance
Dec 10, 2018
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Dec 10, 2018
7 yr 8 mo ago
Today
Pharmaceutical detail
Active ingredient
SILODOSIN
Strength
4MG
Dosage form
CAPSULE
Route
ORAL
TE code
AB
Application
ANDA 210626
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of SILODOSIN
- 2008RAPAFLOBrand (NDA)
NDA 022206 · ABBVIE
- 2025SILODOSINGeneric (ANDA)
ANDA 210396 · TORRENT
- 2022SILODOSINGeneric (ANDA)
ANDA 204816 · ZYDUS PHARMS
- 2022SILODOSINGeneric (ANDA)
ANDA 209029 · PRINSTON INC
- 2022SILODOSINGeneric (ANDA)
ANDA 213230 · CREEKWOOD PHARMS
- 2020SILODOSINGeneric (ANDA)
ANDA 204793 · HETERO LABS LTD V
- 2019SILODOSINGeneric (ANDA)
ANDA 211731 · ALEMBIC
- 2018SILODOSINGeneric (ANDA)
ANDA 211060 · AJANTA PHARMA LTD
- 2018SILODOSINGeneric (ANDA)
ANDA 209745 · AMNEAL PHARMS CO
- 2018SILODOSINGeneric (ANDA)
ANDA 206541 · LUPIN
- 2018SILODOSINGeneric (ANDA)
ANDA 211166 · MACLEODS PHARMS LTD
- 2018SILODOSINGeneric (ANDA)
ANDA 210687 · MSN
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
